Abstract
Introduction/Background*New/emerging therapies based on microsatellite instability (MSI) prognostic biomarker are altering the treatment landscape for advanced endometrial cancer (aEC). The real-world outcomes in aEC patients with MSI-high/deficient mismatch repair (MSI-H/dMMR)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have